Although we performed a rigorous case–control study to reveal a link and possible mechanisms between CYP17A1 polymorphisms and T2DM using meticulous multilevel statistics and bioinformatics analysis, there are also several limitations to our study. This evidence concerns the gene CYP17A1 and type 2 diabetes mellitus.